This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cybex Reports Appellate Decision In Product Liability Suit

Cybex International (NASDAQ: CYBI), a leading manufacturer of premium exercise equipment, reported today that the Appellate Division, Fourth Judicial Department, of the Supreme Court of the State of New York, has rendered a decision in the Company’s appeal of the previously announced jury verdict in the product liability litigation, Barnhard v. Cybex International, Inc. The Appellate Division reduced the judgment by approximately 31%, to approximately $44 million. Under New York law, Cybex is responsible for payment of the judgment but will seek reimbursement from the co-defendant of approximately 21% of its payments on the judgment, which results in a net liability to Cybex, after insurance, of approximately $33 million plus interest at the annual rate of 9% which accrues on the modified judgment from the judgment date. The judgment was otherwise affirmed.

Cybex Chairman and CEO John Aglialoro stated, “Cybex strongly believes that it was not at fault in the accident that is the basis of the plaintiff’s claims and that this case was wrongly decided as to liability. In addition, while the Company appreciates the decision of the Court to reduce the judgment, we believe that the amount of damages represented by the reduced judgment continues to be overstated. Accordingly, we will petition the Court of Appeals of the State of New York to consider our appeal of the judgment.”

Cybex expects within 60 days a decision by the Court of Appeals whether to accept for consideration the Company’s appeal and, if the appeal is accepted, it expects a ruling on the merits during 2012. The Company is also exploring both ways to protect itself in the event the Court of Appeals does not accept the appeal for consideration and available alternatives to fund an ultimate resolution of the matter.

Cybex is analyzing the impact that the appellate decision, which will result in a reduction in the Barnhard net litigation reserve, will have on fourth quarter and full year results.

The Company will hold a conference call on Tuesday, November 22, 2011 at 4:30 p.m. ET to provide a Business Update on this matter. Those who wish to participate may dial (800) 946-0774 from the U.S. or (719) 325-2313 for international callers. A live webcast of the conference call will be available on Cybex’s website at www.cybexintl.com in the Company Press section. Participants should visit the website at least 15 minutes early to register for the teleconference webcast and download the necessary software.

A replay of the call will be available starting Tuesday, November 22, 2011 at 7:30 p.m. ET and lasting through Friday, December 2, 2011 by dialing (877) 870-5176 or (858) 384-5517 for international callers. The access code for the replay is 8269744.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs